Updated May 28 at 5:25am
Biotechnology
32 results total, viewing 21 - 30
(Updated, 9:20 p.m.) IlluminOss Medical has appointed Manny Avila as its new president and CEO. The developer of a minimally invasive system to repair bone fractures has been looking for a chief executive since former president and CEO Dirk Kuyper left in September 2014. more
Mnemosyne Pharmaceuticals has changed its name to Luc Therapeutics and moved its headquarters from Providence to Cambridge. more
Nabsys Inc., a life sciences company that was trying to bring its genome-mapping products to market, closed recently, throwing approximately 40 people out of work. more
Medtronic PLC, the world’s biggest maker of heart-rhythm devices, reported first-quarter profit that topped analysts’ estimates on strong demand for its newest products to monitor the heart and repair damaged valves. more
A biomedical engineering professor at the University of Rhode Island has received a $6 million National Science Foundation grant for research to show how the nervous system functions in health and disease. more
Amgen Inc. won U.S. approval for its powerful cholesterol-lowering drug Repatha for certain patients, making it the second in a new class of treatments to come to market. more
Medtronic PLC will spend as much as $458 million to buy Twelve Inc., becoming the latest medical-device giant to buy an experimental product to replace the heart’s mitral valve without open-heart surgery. more
(Updated, 4 p.m., Aug. 21) Some of the region’s most notable companies have been named in Providence Business News’ fourth Fastest-Growing & Innovative Companies awards program. more
(Updated, 5:40 p.m.) Ximedica announced Tuesday it has purchased the San Francisco-based Bridge Design, providing the Rhode Island-based medical technology development company with a West Coast hub. more
Tivorsan Pharmaceuticals Inc. has named James E. Connolly CEO. The biotechnology company, which focuses on treating Duchenne Muscular Dystrophy and other neuromuscular disorders, also said that Connolly will serve as a member of its board. more
« Prev | 1 | 2 | 3 | 4 Next »